Posterpreise 2013 Der Doktorandenpreis ging an:
Posterpreise
3 gleichwertige Posterpreise à EUR 1.000 gingen an: P53 E3 ubiquitin protein ligase homolog (mouse) (MDM-2) immunoexpression is a strong predictor of poor overall survival in malignant pleural mesothelioma F. Mairinger1, S. Ting2, C. Vollbrecht3, R.F.H. Walter4, J. Kollmeier5, S. Grief6, T. Hager2, T. Mairinger7, D. ChristoPH8, K.W. Schmid2, J. Wohlschläger2 1 Institute of Pathology and Neuropathology, University of DuisburgEssen, University Hospital, Essen, 2 Institute of Pathology and Neuropathology, University of DuisburgEssen, University Hospital, Essen, 3 Institute of Pathology, University Hospital, Cologne, 4 Department of interventional Pneumology, University of Duisburg-Essen, University Hospital, Essen, 5 Heliosklinikum Emil von Behring, Department of Pneumology, Berlin, 6 Heliosklinikum Emil von Behring, Department of Pathology, Berlin, 7 Department of Pathology, HELIOS Klinikum Emil von Behring, Berlin, 8 Department of Oncology, University of Duisburg-Essen, University Hospital, Essen
Functional characterization of CD70, a biomarker specific for clear cell renal cell carcinoma M. Ruf, C. Fieger, M. Rechsteiner, P. Schraml, H. Moch Institute of Surgical Pathology, University Hospital, Zurich, Switzerland
Control of hepatic stellate cells of liver health and disease C. Mogler1, M. Wieland2, V. Sivanandam3, T. Arnsperger2, A. Neumann2, T. Longerich1, P. Schirmacher1, H.G. Augustin3 Institute of Pathology, University Hospital, Heidelberg, German Cancer Research Center, DKFZ, Heidelberg, 3 Division of Vascular Oncology and Metastasis, German Cancer Research Center 1
2
210 |
Der Pathologe · Supplement 2 · 2013
The c-MYC target AP4 mediates epithelial-mesenchymal transition and metastasis in colorectal cancer R. Jackstadt1, J. Neumann2, S. Röh1, P. Jung3, R. Hoffmann4, D. Horst5, C. Berens6, G.W. Bornkamm 7, T. Kirchner 8, A. Menssen 1, H. Hermeking1 1 Institute of Pathology, Experimental and Molecular Pathology, Ludwig-Maximilians-University, Munich, 2 Institute of Pathology, Ludwig-Maximilians-University, Munich, 3 IRB/Institute for Research in Biomedicine, Parc Científic de Barcelona, Spain, 4 Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, 5 Ludwig-Maximilians-University Munich/Institute of Pathology, 6 Department of Biology, Friedrich-Alexander-University, Erlangen-Nürnberg, 7 Institute of Clinical Molecular Biology and Tumor Genetics, Helmholtz Center Munich, 8 Ludwig-Maximilians-University Munich/Institute of Pathology, München
Der GI-Preis ging an: Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway M. Wolf1*, A. Hoos2*, J. Bauer3, S. Böttcher4, M. Knust5, A. Weber1, N. Simonavicius3, C. Schneider6, M. Lang7, M. Stürzl8, R. Croner8, A. Konrad8, M. Manz4, H. Moch1, A. Aguzzi9, G. van Loo10, M. Pasparakis11, M. Prinz7, L. Borsig2, M. Heikenwälder3*, *Authors contributed equally to this work Institute of Surgical Pathology, University Hospital, Zurich, Switzerland, 2 Institute of Physiology, University Hospital, Zurich, Switzerland, 3 Institute of Virology, Technical University of Munich, Munich, 4 Division of Hematology, University Hospital, Zurich, Switzerland, 5 Institute of Neuropathology, University Medical Center, Freiburg, 6 ETH Zurich, Institute of Integrative Biology, Switzerland, 7 Institute of Neuropathology, University of Freiburg, 8 Division of Molecular and Experimental Surgery, FriedrichAlexander University, Erlangen-Nuremberg, 9 Institute of Neuropathology, University Hospital, Zurich, Switzerland, 10 VIB Gent, Department for Molecular Biomedical Research, Gent, Belgium, 11 University of Cologne, Institute of Genetic 1
Posterpreise
3 gleichwertige Posterpreise à EUR 1.000 gingen an: P53 E3 ubiquitin protein ligase homolog (mouse) (MDM-2) immunoexpression is a strong predictor of poor overall survival in malignant pleural mesothelioma F. Mairinger1, S. Ting2, C. Vollbrecht3, R.F.H. Walter4, J. Kollmeier5, S. Grief6, T. Hager2, T. Mairinger7, D. ChristoPH8, K.W. Schmid2, J. Wohlschläger2 1 Institute of Pathology and Neuropathology, University of DuisburgEssen, University Hospital, Essen, 2 Institute of Pathology and Neuropathology, University of DuisburgEssen, University Hospital, Essen, 3 Institute of Pathology, University Hospital, Cologne, 4 Department of interventional Pneumology, University of Duisburg-Essen, University Hospital, Essen, 5 Heliosklinikum Emil von Behring, Department of Pneumology, Berlin, 6 Heliosklinikum Emil von Behring, Department of Pathology, Berlin, 7 Department of Pathology, HELIOS Klinikum Emil von Behring, Berlin, 8 Department of Oncology, University of Duisburg-Essen, University Hospital, Essen
Functional characterization of CD70, a biomarker specific for clear cell renal cell carcinoma M. Ruf, C. Fieger, M. Rechsteiner, P. Schraml, H. Moch Institute of Surgical Pathology, University Hospital, Zurich, Switzerland
Control of hepatic stellate cells of liver health and disease C. Mogler1, M. Wieland2, V. Sivanandam3, T. Arnsperger2, A. Neumann2, T. Longerich1, P. Schirmacher1, H.G. Augustin3 Institute of Pathology, University Hospital, Heidelberg, German Cancer Research Center, DKFZ, Heidelberg, 3 Division of Vascular Oncology and Metastasis, German Cancer Research Center 1
2
210 |
Der Pathologe · Supplement 2 · 2013
The c-MYC target AP4 mediates epithelial-mesenchymal transition and metastasis in colorectal cancer R. Jackstadt1, J. Neumann2, S. Röh1, P. Jung3, R. Hoffmann4, D. Horst5, C. Berens6, G.W. Bornkamm 7, T. Kirchner 8, A. Menssen 1, H. Hermeking1 1 Institute of Pathology, Experimental and Molecular Pathology, Ludwig-Maximilians-University, Munich, 2 Institute of Pathology, Ludwig-Maximilians-University, Munich, 3 IRB/Institute for Research in Biomedicine, Parc Científic de Barcelona, Spain, 4 Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, 5 Ludwig-Maximilians-University Munich/Institute of Pathology, 6 Department of Biology, Friedrich-Alexander-University, Erlangen-Nürnberg, 7 Institute of Clinical Molecular Biology and Tumor Genetics, Helmholtz Center Munich, 8 Ludwig-Maximilians-University Munich/Institute of Pathology, München
Der GI-Preis ging an: Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway M. Wolf1*, A. Hoos2*, J. Bauer3, S. Böttcher4, M. Knust5, A. Weber1, N. Simonavicius3, C. Schneider6, M. Lang7, M. Stürzl8, R. Croner8, A. Konrad8, M. Manz4, H. Moch1, A. Aguzzi9, G. van Loo10, M. Pasparakis11, M. Prinz7, L. Borsig2, M. Heikenwälder3*, *Authors contributed equally to this work Institute of Surgical Pathology, University Hospital, Zurich, Switzerland, 2 Institute of Physiology, University Hospital, Zurich, Switzerland, 3 Institute of Virology, Technical University of Munich, Munich, 4 Division of Hematology, University Hospital, Zurich, Switzerland, 5 Institute of Neuropathology, University Medical Center, Freiburg, 6 ETH Zurich, Institute of Integrative Biology, Switzerland, 7 Institute of Neuropathology, University of Freiburg, 8 Division of Molecular and Experimental Surgery, FriedrichAlexander University, Erlangen-Nuremberg, 9 Institute of Neuropathology, University Hospital, Zurich, Switzerland, 10 VIB Gent, Department for Molecular Biomedical Research, Gent, Belgium, 11 University of Cologne, Institute of Genetic 1
